Fedha

Hisa unazofuatilia
BIIB34:BVMF
Biogen Inc BDR
R$ 184.49
0.00%
(0.00) Siku 1
5 Okt, 15:59:13 GMT -3  ·   BRL
Alama zote
AlamaBeiTofautiTofauti ya asilimia
Inatayarisha maarifa maarufu ya BIIB34...
Mtaji wa soko
32.82B
Wastani wa kiasi cha mauzo
7.00
Kiasi cha mauzo ya hisa
0.00
Juu kwa wiki 52
R$ 191.00
Chini kwa wiki 52
R$ 128.69
Hisa za wawekezaji
147.75M
Idadi ya wafanyakazi
elfu 8
Mtaji wa soko
32.82B
Wastani wa kiasi cha mauzo
7.00
Kiasi cha mauzo ya hisa
0.00
Juu kwa wiki 52
R$ 191.00
Chini kwa wiki 52
R$ 128.69
Hisa za wawekezaji
147.75M
Idadi ya wafanyakazi
elfu 8
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Wasifu
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the treatment of neurological diseases. The company's primary products are dimethyl fumarate, diroximel fumarate, interferon beta-1a, peginterferon beta-1a, and natalizumab, all for the treatment of multiple sclerosis; nusinersen for the treatment of spinal muscular atrophy; omaveloxolone for the treatment of Friedreich's ataxia; tofersen for the treatment of ALS; and dimethyl fumarate for the treatment of severe plaque psoriasis. The company also produces 5 biosimilars and has collaborations with Genentech for several drugs. The company is ranked 424th on the Fortune 500 and 845th on the Forbes Global 2000. Wikipedia
Kuhusu Biogen Inc BDR
Afisa Mkuu Mtendaji (CEO)Chris Viehbacher
Wafanyakazielfu 7.5
Lilianzishwa1978
Makao makuuCambridge, Massachusetts, Marekani
Sekta-
Tovutibiogen.com
Ripoti ya mwisho
29 Jul 2026
Kipindi cha Kifedha
Robo2 2026
Mapato kwa kila hisa dhidi ya makadirio (USD)
US$ 3.60 / US$ 2.03
+77.38%umepitiliza
Mapato dhidi ya makadirio (USD)
2.74B / 2.46B
+11.19%umepitiliza
Mkutano pepe wa kujadili mapato ya robo ya Robo ya 2 ya mwaka wa fedha wa 2026
Inasubiri mkutano pepe wa kujadili mapato
Kwa muhtasari
Maarifa kutoka kwenye ripoti na habari za hivi punde
Ripoti za awaliThamani zote katika USD
Loading Previous Earnings...
Mapato
Mapato halisi
Thamani zote katika USD
Sep 2025
Des 2025
Mac 2026
Jun 2026
Mapato
2.53B
2.28B
2.48B
2.74B
Gharama ya bidhaa zilizouzwa
508.60M
443.40M
610.20M
611.60M
Gharama ya mapato
508.60M
443.40M
610.20M
611.60M
Gharama za utafiti na maendeleo
431.80M
477.10M
482.20M
492.10M
Jumla ya gharama za utafiti na maendeleo
-
-
-
-
Gharama za uuzaji, za jumla na za usimamizi
592.80M
685.20M
607.30M
709.70M
Gharama ya uendeshaji
1.25B
1.36B
1.30B
1.44B
Jumla ya gharama za uendeshaji
1.76B
1.81B
1.91B
2.05B
Mapato ya uendeshaji
778.60M
471.60M
567.40M
685.60M
Mapato mengine yasiyo ya uendeshaji
15.80M
17.40M
-1.10M
3.00M
EBT ikijumuisha vipengee visivyo vya kawaida
557.30M
-56.00M
377.70M
132.40M
EBT bila kujumuisha vipengee visivyo vya kawaida
748.30M
447.00M
530.10M
625.10M
Gharama ya kodi ya mapato
90.80M
-7.10M
58.20M
34.90M
Kiwango cha kodi kinachotumika
16.29%
12.68%
15.41%
26.36%
Gharama nyingine za uendeshaji
87.20M
69.90M
74.20M
68.80M
Mapato halisi
466.50M
-48.90M
319.50M
97.50M
Kiwango cha faida halisi
18.40%
-2.15%
12.89%
3.56%
Mapato kwa kila hisa
4.81
1.99
3.57
3.60
Mapato ya riba na uwekezaji
31.60M
37.20M
37.90M
25.30M
Gharama ya riba
-67.40M
-67.50M
-67.60M
-82.30M
Jumla ya gharama halisi za riba
-35.80M
-30.30M
-29.70M
-57.00M
Gharama za kushuka kwa thamani na za kulipa deni
-
-
-
-
Mapato ya kampuni kabla ya riba, kodi, kushuka thamani na kulipa madeni
980.80M
671.80M
771.80M
921.70M
Faida au hasara kutokana na uuzaji wa vipengee
-
-
-
-
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
UsaidiziTuma maoniFaraghaSheria na MashartiKanusho
Programu za Google